Internal Manufacturing Capabilities Are Critical To Level-Up eTheRNA
eTheRNA CEO Steven Powell On Growing The Biotech In The 2020s
Executive Summary
A year into his role as a CEO of the Belgian mRNA biotech eTheRNA immunotherapies, industry veteran Steven Powell talks to In Vivo about his plans for the business over the coming couple of years. An important timeframe to move the company well into clinical activity.